Research conducted at Oxford University used new scanning method
News
Colchicine added to UK’s COVID-19 ‘RECOVERY’ trial
Commonly used anti-inflammatory drug added to list of potential treatments
Researchers warn pandemic could delay cancer advances ‘by almost a year’
Survey included input from scientists at The Institute of Cancer Research, London
Dupixent approved in EU for atopic dermatitis in children
First biologic to be approved for children aged six to 11 years with condition
UK secures another two million doses of Moderna’s COVID-19 vaccine
New agreement takes supply up to seven million doses in total
Symkevi/Kalydeco cleared for use in young CF patients
The combination is the first available to treat the underlying cause of CF in this patient group.
EU to review Merck’s targeted lung cancer drug
Tepotinib could be the first treatment on the market for NSCLC in adults harbouring METex14 skipping alterations
NICE turns down Novartis’ Adakveo
Trial results and cost-effectiveness are too uncertain for NHS use, the Institute said
NHS to trial innovative cancer blood test
It is hoped that the test will help detect cancer at a much earlier stage
NICE backs use of new treatment for multiple myeloma
Sanofi’s Sarclisa gets the final green light for use by the NHS with funding from the CDF
Moderna signs deal with EU for 160 million COVID-19 vaccine doses
Delivery of vaccine doses to EU could begin by early 2021
Janssen’s Tremfya approved for active psoriatic arthritis
Tremfya is a first-in-class treatment for the disease, shown to improve disease measures and quality of life
Mixed reaction to chancellor’s spending review
Chancellor Rishi Sunak hands out extra £3 billion to NHS and £14.6 billion in funding for R&D
BMS inks drug discovery deal with Schrödinger
Deal will focus on developing small molecules against a number of diseases
COVID-19 pandemic has emphasised existing health inequalities, research finds
New report conducted by Imperial College London researchers and Philips UK highlights issues within the NHS
